There has been a lot of curiosity about the continued developments in the psychedelic therapy space recently. Designer drugs such as, Psilocybin, 3,4-Methylenedioxymethamphetamine (MDMA) and lysergic acid diethylamide (LSD) have started to emerge within the athletic space.
In May of 2019, a video was leaked featuring the Washington Capitals’ Evgeny Kuznetsov sitting near two lines of a white, powder-like substance that many presumed to be cocaine. It was taken while the team was in Las Vegas to play the Golden Knights. When I read this it immediately prompted me to find out more about what this substance does to the brain which is why I recruited the wonderful Dr David Rabin, MD PhD to the neuro experience podcast via clubhouse.
Dr. Rabin specializes in treatment-resistant mental illnesses including depression, anxiety, post-traumatic stress disorder (PTSD), psychosomatic disorders, personality disorders, chronic pain disorders, insomnia, and substance use disorders using minimal and non-invasive treatment strategies.
“Psychedelic medicine is unique because it allows us, whether it's MDMA or LSD, or psilocybin or ketamine, to step outside of that default mode and look back at ourselves, and really reappraise what it means to be us,” he says.
To take advantage of deals from our partners, head to the following links to claim your offer:
Athletic Greens: athleticgreens.com/neuro
AmpHuman: AmpHuman.com - Enter code: Neuro15 for 15% off anything on the site.